ANN ARBOR, Mich., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM - News), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will speak at the Piper Jaffray 23rd Annual Health Care Conference, which is being held November 29-30, 2011 in New York City. The Aastrom presentation will take place at 2:30 PM (EST) on Tuesday, November 29, 2011. The presentation will be webcast live and will also be accessible in archive until February 27, 2012, beginning one hour after the presentation. The URL for live and archived access to the presentation is: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ASTM&item_id=4228878.
